Drug Database
Back to search

United States· US:71288-034_eb1f6798-3443-4fa7-95fc-fe4a387de46d

Dalbavancin

A dalbavancin product containing dalbavancin hydrochloride, registered in United States by Meitheal Pharmaceuticals Inc. The same ATC class is registered in 16 of our 19 countries.

ATC J01XA04US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDalbavancinATCJ01XA04REGISTER NO.US:71288-034_eb1f6798…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dalbavancin hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dalbavancin is registered in 16 of 19 countries.

Countries holding a registration under ATC J01XA04 (dalbavancin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose
Search dalbavancin products by name

Dalbavancin · ATC J01XA04

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DALBAVANCIN HYDROCHLORIDE
Manufacturer
Meitheal Pharmaceuticals Inc
Country
United States (US)
ATC code
J01XA04
ATC class
Dalbavancin
Defined daily dose
1.5 g, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    7128803450
    1 VIAL, SINGLE-DOSE in 1 CARTON (71288-034-50) / 25 mL in 1 VIAL, SINGLE-DOSE
  • ndc11
    71288-034-50

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

7 interactions on record for dalbavancin.

Graded by severity as the source publishes them — 7 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dalbavancin against other medicinesHow interaction checks work

Dalbavancin · interactions on record

7 records

  • 7 moderate

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • Levonorgestrel and ethinylestradiolG03AA07moderate
  • Desogestrel and ethinylestradiolG03AA09moderate
  • Drospirenone and ethinylestradiolG03AA12moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dalbavancin in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dalbavancin products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Dalbavancin, Dalbavancin Newbury
  • Belgium · Dalbavancin Baxter, Dalbavancine Baxter
  • Denmark · Dalbavancin Baxter
  • Spain · Dalbavancina Baxter
  • Finland · Dalbavancin Baxter
  • France · Dalbavancine
  • United Kingdom (Northern Ireland) · Dalbavancin Baxter, Dalbavancin Teva
  • Italy · Dalbavancina
  • Luxembourg · Dalbavancin, Dalbavancine
  • Netherlands · Dalbavancine Baxter
  • Norway · Dalbavancin
  • Sweden · Dalbavancin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6bee7856-524b-4e5e-8d51-25a443959a8a
GET /v1/drugs/6bee7856-524b-4e5e-8d51-25a443959a8a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "500",
  "substance": "DALBAVANCIN HYDROCHLORIDE",
  "productndc": "71288-034",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/25mL",
  "application_number": "ANDA218929",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about dalbavancin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console